6.16
6.16 (0%)
As of Feb 14, 2025
Bausch Health Companies Inc. [BHC]
Source:
Company Overview
Bausch Health Companies Inc. is a global, diversified specialty pharmaceutical and medical device company that develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (“GI”), hepatology, neurology and dermatology.
| Country | United States |
| Headquarters | quebec |
| Phone Number | 514-744-6792 |
| Industry | manufacturing |
| CEO | Thomas J. Appio Thomas Appio |
| Website | www.bauschhealth.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $9,625 |
| Operating Profit | $1,546 |
| Net Income | $-72 |
| Net Cash | $239 |
Profit Ratios
| Gross Margin | $9,625 |
| Operating Margin | 16.1 |
| Profit as % of Revenues | -13,368.1% |
| Profit as % of Assets | -0.3% |
| Profit as % of Stockholder Equity | 22.4% |
Management Effectiveness
| Return on Equity | 22.4% |
| Return on Assets | -0.3% |
| Turnover Ratio | 35.7% |
| EBITA | $2,623 |
Balance Sheet and Cash Flow Measures
| Total Assets | $26,523 |
| Total Liabilities | $26,845 |
| Operating Cash Flow | $1,597 |
| Investing Cash Flow | $-454 |
| Financing Cash Flow | $-868 |
